Diversified Healthcare Trust (DHC) attracts a new wave of investors despite economic turmoil

The closing price of Diversified Healthcare Trust (NASDAQ: DHC) was $1.53 for the day, down -3.16% from the previous closing price of $1.58. In other words, the price has decreased by -$0.0500 from its previous closing price. On the day, 2527248 shares were traded. DHC stock price reached its highest trading level at $1.5700 during the session, while it also had its lowest trading level at $1.4300.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".



Our analysis of DHC’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 1.16.

Upgrades & Downgrades

Wells Fargo Downgraded its Overweight to Equal Weight on January 17, 2020, while the target price for the stock was maintained at $9.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.34 while its Price-to-Book (P/B) ratio in mrq is 0.14.

Stock Price History:

Over the past 52 weeks, DHC has reached a high of $3.28, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 0.9460, while the 200-Day Moving Average is calculated to be 1.2902.

Shares Statistics:

DHC traded an average of 5.09M shares per day over the past three months and 7.36M shares per day over the past ten days. A total of 238.56M shares are outstanding, with a floating share count of 236.44M. Insiders hold about 0.10% of the company’s shares, while institutions hold 82.30% stake in the company. Shares short for DHC as of Jan 12, 2023 were 5.4M with a Short Ratio of 5.20M, compared to 8.14M on Dec 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.25% and a Short% of Float of 3.53%.

Dividends & Splits

With its trailing 12-month dividend rate of 0.04, DHC has a forward annual dividend rate of 0.04. Against a Trailing Annual Dividend Yield of 2.53%, it implies a Forward Annual Dividend Yield of 5.73%. The stock’s 5-year Average Dividend Yield is 7.05.

Earnings Estimates

The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of -$0.26 for the current quarter, with a high estimate of -$0.24 and a low estimate of -$0.28, while EPS last year was -$0.4. The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.21 and low estimates of -$0.26.

Analysts are recommending an EPS of between $0.07 and -$0.07 for the fiscal current year, implying an average EPS of $0. EPS for the following year is -$0.89, with 2 analysts recommending between -$0.79 and -$1.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 4 analysts. It ranges from a high estimate of $338.75M to a low estimate of $322.23M. As of the current estimate, Diversified Healthcare Trust’s year-ago sales were $336.73M, an estimated decrease of -2.00% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $334.79M, an increase of 7.70% over than the figure of -$2.00% in the same quarter last year. There is a high estimate of $344.39M for the next quarter, whereas the lowest estimate is $326.35M.

A total of 4 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.29B, while the lowest revenue estimate was $1.27B, resulting in an average revenue estimate of $1.28B. In the same quarter a year ago, actual revenue was $1.38B, down -7.70% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $1.37B in the next fiscal year. The high estimate is $1.43B and the low estimate is $1.32B. The average revenue growth estimate for next year is up 7.10% from the average revenue estimate for this year.